Company intelligence / Profile preview
Reviva Pharmaceuticals
Cupertino, California, United Statesrevivapharma.com ↗
- Ownership
- Public · RVPH
- Development stage
- Phase 3
01
Overview
Reviva’s lead candidate brilaroxazine has demonstrated robust efficacy and safety in both Phase 2 and pivotal Phase 3 trials for schizophrenia. The RECOVER Phase 3 trial met all primary and secondary endpoints with statistically significant improvements across major symptom domains. Long-term open-label extension data show sustained efficacy over one year with favorable tolerability. NDA submission targeted for late 2026[1][3][8].
- Therapeutic areas
- PsychiatryCardiovascularMetabolic DisordersImmunologyNeurology
- Modalities
- small molecules (new chemical entities)[1][2][7]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical partnerships have been announced as of the latest available information.
04
Financials
- Market cap
- $6.5M
- Total revenue
- $0
- Enterprise value
- $-19.7T
Beyond the preview
Go deeper on Reviva Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reviva Pharmaceuticals.